These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 31605492)

  • 1. Calciprotein particle inhibition explains magnesium-mediated protection against vascular calcification.
    Ter Braake AD; Eelderink C; Zeper LW; Pasch A; Bakker SJL; de Borst MH; Hoenderop JGJ; de Baaij JHF
    Nephrol Dial Transplant; 2020 May; 35(5):765-773. PubMed ID: 31605492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of Serum Calciprotein Particle Size and Transformation Time With Arterial Calcification, Arterial Stiffness, and Mortality in Incident Hemodialysis Patients.
    Chen W; Fitzpatrick J; Monroy-Trujillo JM; Sozio SM; Jaar BG; Estrella MM; Serrano J; Anokhina V; Miller BL; Melamed ML; Bushinsky DA; Parekh RS
    Am J Kidney Dis; 2021 Mar; 77(3):346-354. PubMed ID: 32800846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with advanced chronic kidney disease and vascular calcification have a large hydrodynamic radius of secondary calciprotein particles.
    Chen W; Anokhina V; Dieudonne G; Abramowitz MK; Kashyap R; Yan C; Wu TT; de Mesy Bentley KL; Miller BL; Bushinsky DA
    Nephrol Dial Transplant; 2019 Jun; 34(6):992-1000. PubMed ID: 29788425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of calcium phosphate crystals on calcified human aortic vascular smooth muscle cells and potential role of magnesium.
    Louvet L; Bazin D; Büchel J; Steppan S; Passlick-Deetjen J; Massy ZA
    PLoS One; 2015; 10(1):e0115342. PubMed ID: 25607936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnesium and calciprotein particles in vascular calcification: the good cop and the bad cop.
    Zeper LW; de Baaij JHF
    Curr Opin Nephrol Hypertens; 2019 Jul; 28(4):368-374. PubMed ID: 31045659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver and spleen predominantly mediate calciprotein particle clearance in a rat model of chronic kidney disease.
    Zeper LW; Bos C; Leermakers PA; Franssen GM; Raavé R; Hoenderop JGJ; de Baaij JHF
    Am J Physiol Renal Physiol; 2024 Apr; 326(4):F622-F634. PubMed ID: 38420675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic Kidney Disease Circulating Calciprotein Particles and Extracellular Vesicles Promote Vascular Calcification: A Role for GRP (Gla-Rich Protein).
    Viegas CSB; Santos L; Macedo AL; Matos AA; Silva AP; Neves PL; Staes A; Gevaert K; Morais R; Vermeer C; Schurgers L; Simes DC
    Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):575-587. PubMed ID: 29301790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calciprotein Particle Synthesis Strategy Determines In Vitro Calcification Potential.
    Zeper LW; Smith ER; Ter Braake AD; Tinnemans PT; de Baaij JHF; Hoenderop JGJ
    Calcif Tissue Int; 2023 Jan; 112(1):103-117. PubMed ID: 36326853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Secondary Calciprotein Particles in the Mineralisation Paradox of Chronic Kidney Disease.
    Cai MMX; Smith ER; Tan SJ; Hewitson TD; Holt SG
    Calcif Tissue Int; 2017 Dec; 101(6):570-580. PubMed ID: 28861648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel assessments of systemic calcification propensity.
    Pasch A
    Curr Opin Nephrol Hypertens; 2016 Jul; 25(4):278-84. PubMed ID: 27228365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new in vitro model to delay high phosphate-induced vascular calcification progression.
    Ciceri P; Elli F; Cappelletti L; Tosi D; Braidotti P; Bulfamante G; Cozzolino M
    Mol Cell Biochem; 2015 Dec; 410(1-2):197-206. PubMed ID: 26346159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zinc Inhibits Phosphate-Induced Vascular Calcification through TNFAIP3-Mediated Suppression of NF-
    Voelkl J; Tuffaha R; Luong TTD; Zickler D; Masyout J; Feger M; Verheyen N; Blaschke F; Kuro-O M; Tomaschitz A; Pilz S; Pasch A; Eckardt KU; Scherberich JE; Lang F; Pieske B; Alesutan I
    J Am Soc Nephrol; 2018 Jun; 29(6):1636-1648. PubMed ID: 29654213
    [No Abstract]   [Full Text] [Related]  

  • 13. Calcification of vascular smooth muscle cells is induced by secondary calciprotein particles and enhanced by tumor necrosis factor-α.
    Aghagolzadeh P; Bachtler M; Bijarnia R; Jackson C; Smith ER; Odermatt A; Radpour R; Pasch A
    Atherosclerosis; 2016 Aug; 251():404-414. PubMed ID: 27289275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnesium to prevent kidney disease-associated vascular calcification: crystal clear?
    Ter Braake AD; Vervloet MG; de Baaij JHF; Hoenderop JGJ
    Nephrol Dial Transplant; 2022 Feb; 37(3):421-429. PubMed ID: 33374019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of serum zinc with mineral stress in chronic kidney disease.
    Sohail A; Obereigner J; Mitter G; Schmid T; Hofer AS; Schuster G; Hügl A; Dorninger AH; Mandl M; Pasch A; Lackner HK; Papousek I; Dieplinger B; Suessner S; Antlanger M; Cejka D; Alesutan I; Voelkl J
    Clin Kidney J; 2024 Sep; 17(9):sfae258. PubMed ID: 39286240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnesium prevents vascular calcification in vitro by inhibition of hydroxyapatite crystal formation.
    Ter Braake AD; Tinnemans PT; Shanahan CM; Hoenderop JGJ; de Baaij JHF
    Sci Rep; 2018 Feb; 8(1):2069. PubMed ID: 29391410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of Vascular Calcification in Kidney Disease.
    Disthabanchong S; Srisuwarn P
    Adv Chronic Kidney Dis; 2019 Nov; 26(6):417-426. PubMed ID: 31831120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II prevents calcification in vascular smooth muscle cells by enhancing magnesium influx.
    Herencia C; Rodríguez-Ortiz ME; Muñoz-Castañeda JR; Martinez-Moreno JM; Canalejo R; Montes de Oca A; Díaz-Tocados JM; Peralbo-Santaella E; Marín C; Canalejo A; Rodriguez M; Almaden Y
    Eur J Clin Invest; 2015 Nov; 45(11):1129-44. PubMed ID: 26268950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and 3-month effects of calcium carbonate on the calcification propensity of serum and regulators of vascular calcification: secondary analysis of a randomized controlled trial.
    Bristow SM; Gamble GD; Pasch A; O'Neill WC; Stewart A; Horne AM; Reid IR
    Osteoporos Int; 2016 Mar; 27(3):1209-1216. PubMed ID: 26493812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study on biorelevant calciprotein particles: Effect of stabilizing agents on the formation and crystallization mechanisms.
    Gelli R; Pucci V; Ridi F; Baglioni P
    J Colloid Interface Sci; 2022 Aug; 620():431-441. PubMed ID: 35439694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.